Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Intercept Pharmaceuticals (ICPT)

Intercept Pharmaceuticals (ICPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 793,877
  • Shares Outstanding, K 41,783
  • Annual Sales, $ 285,710 K
  • Annual Income, $ 221,820 K
  • 60-Month Beta 0.88
  • Price/Sales 2.77
  • Price/Cash Flow N/A
  • Price/Book 11.05
Trade ICPT with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -4.37
  • Most Recent Earnings $-0.07 on 11/06/23
  • Latest Earnings Date 11/07/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.02
  • Number of Estimates 8
  • High Estimate 0.36
  • Low Estimate -0.36
  • Prior Year -0.42
  • Growth Rate Est. (year over year) +95.24%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.01 +11.67%
on 10/13/23
19.02 -0.11%
on 11/06/23
+0.40 (+2.15%)
since 10/06/23
3-Month
9.70 +95.88%
on 08/14/23
19.02 -0.11%
on 11/06/23
+8.61 (+82.87%)
since 08/07/23
52-Week
8.82 +115.38%
on 05/24/23
21.86 -13.08%
on 02/08/23
+3.68 (+24.02%)
since 11/07/22

Most Recent Stories

More News
Intercept: Q3 Earnings Snapshot

Intercept: Q3 Earnings Snapshot

ICPT : 19.00 (+0.21%)
Moore Kuehn Encourages ICPT, SRT, PCTI, and SP Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

ICPT : 19.00 (+0.21%)
SRT : 4.42 (+1.14%)
PCTI : 6.99 (-0.14%)
SP : 51.67 (-0.63%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMTI, ICPT, FNCB

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AMTI : 0.2630 (-14.30%)
ICPT : 19.00 (+0.21%)
FNCB : 5.39 (+0.19%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMTI, CHS, FNCB, ICPT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AMTI : 0.2630 (-14.30%)
CHS : 7.59 (-0.13%)
FNCB : 5.39 (+0.19%)
ICPT : 19.00 (+0.21%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPLK, ICPT, CHS, AMTI

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

SPLK : 156.90 (+0.25%)
ICPT : 19.00 (+0.21%)
CHS : 7.59 (-0.13%)
AMTI : 0.2630 (-14.30%)
Moore Kuehn Encourages AMTI, SPLK, ICPT, and CHS Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

AMTI : 0.2630 (-14.30%)
SPLK : 156.90 (+0.25%)
ICPT : 19.00 (+0.21%)
CHS : 7.59 (-0.13%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICPT, PFSW, AVTA, CATC

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ICPT : 19.00 (+0.21%)
PFSW : 7.49 (unch)
AVTA : 25.99 (-0.04%)
CATC : 61.39 (-0.29%)
Why Intercept Pharmaceuticals Stock Is Skyrocketing Today

Intercept is on track to be acquired by Alfasigma at a significant premium compared to recent prices.

ICPT : 19.00 (+0.21%)
Shareholder Alert: Ademi LLP investigates whether Intercept Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Alfasigma

/PRNewswire/ -- Ademi LLP is investigating Intercept (Nasdaq: ICPT) for possible breaches of fiduciary duty and other violations of law in its transaction with...

ICPT : 19.00 (+0.21%)
Why CymaBay Therapeutics Stock Is Jumping Today

The momentum continues after CymaBay reported great clinical results on Thursday.

ICPT : 19.00 (+0.21%)
CBAY : 32.48 (+0.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Intercept Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing novel therapeutics to treat chronic liver diseases to market. The company's focus is on treating orphan and more prevalent liver diseases with limited treatment options. The company received FDA approval for Ocaliva an...

See More

Key Turning Points

3rd Resistance Point 19.04
2nd Resistance Point 19.03
1st Resistance Point 19.01
Last Price 19.00
1st Support Level 18.98
2nd Support Level 18.97
3rd Support Level 18.95

See More

52-Week High 21.86
Last Price 19.00
Fibonacci 61.8% 16.88
Fibonacci 50% 15.34
Fibonacci 38.2% 13.80
52-Week Low 8.82

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar